PE: How do global pharma growth strategies differ from domestic strategies? Ackerman: There are two different models for ...

Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long ...

Shandong Xinhua Pharmaceutical Company Limited Class H ( ($HK:0719) ) has provided an update. Shandong Xinhua Pharmaceutical Company Limited has ...

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says ...

Impiricus, a platform that connects healthcare providers with pharmaceutical and life sciences companies for equitable access to resources and improved patient care, today announced the launch of ...

The German chemicals and pharmaceutical industry faced further setbacks in the third quarter, with turnover falling 2. 3% ...

At just 19, Sheetal Arora was thrown in at the deep end of operations at Mankind Pharma. Though a family-run enterprise, he ...

For the third quarter of 2025, Ascendis Pharma reported a net loss of €61.0 million, or €1.00 per share basic and diluted compared to a net loss of €99.2 million, or €1.72 per share basic and diluted ...

The future of engagement isn’t about mapping journeys for HCPs. It’s about earning relevance inside the journeys they’re already living.

NEW DELHI : The Centre has extended the deadline for applying for the ₹ 5,000-crore Promotion of Research and Innovation in ...

Postpartum depression descended on Kristina Leos like a heavy fog that separated her from everyone she loved. She could see ...